Agios Pharm Working Capital to Net Assets Ratio
Agios Pharm working capital to net assets ratio. Agios Pharm (AGIO) has a Working Capital to Net Assets ratio of 63.1% as of June 2026. Working capital of $647.45 Million (current assets of $717.67 Million minus current liabilities of $70.22 Million) is measured against net assets of $1.03 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check AGIO intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Agios Pharm (2011–2025)
Working capital to net assets ratio of Agios Pharm from 2011 to 2025. This chart shows how Agios Pharm's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 63.1%, reflecting working capital of $647.45 Million against net assets of $1.03 Billion USD. See how many days can Agios Pharm fund operations to measure how many days the company can operate on defensive assets alone.
Agios Pharm Working Capital to Net Assets Ratio by Year (2011–2025)
Agios Pharm working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Agios Pharm from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Agios Pharm balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 72.1% | $859.85 Million | $1.19 Billion | $942.05 Million | $82.21 Million | ▲ +14.7 pp |
| 2024 | 57.4% | $884.44 Million | $1.54 Billion | $965.60 Million | $81.16 Million | ▼ -37.0 pp |
| 2023 | 94.4% | $765.88 Million | $811.02 Million | $833.84 Million | $67.95 Million | ▲ +24.5 pp |
| 2022 | 70.0% | $770.14 Million | $1.10 Billion | $832.77 Million | $62.63 Million | ▼ -7.8 pp |
| 2021 | 77.7% | $1.00 Billion | $1.29 Billion | $1.06 Billion | $59.83 Million | ▼ -58.0 pp |
| 2020 | 135.7% | $542.28 Million | $399.50 Million | $636.68 Million | $94.39 Million | ▲ +54.7 pp |
| 2019 | 81.0% | $518.82 Million | $640.53 Million | $611.70 Million | $92.89 Million | ▲ +5.3 pp |
| 2018 | 75.7% | $520.28 Million | $687.54 Million | $613.78 Million | $93.50 Million | ▼ -17.6 pp |
| 2017 | 93.3% | $350.32 Million | $375.50 Million | $445.26 Million | $94.94 Million | ▼ -38.2 pp |
| 2016 | 131.5% | $471.46 Million | $358.59 Million | $559.89 Million | $88.43 Million | ▲ +49.1 pp |
| 2015 | 82.4% | $284.44 Million | $345.12 Million | $337.33 Million | $52.89 Million | ▲ +12.1 pp |
| 2014 | 70.3% | $298.46 Million | $424.37 Million | $359.55 Million | $61.09 Million | ▼ -30.7 pp |
| 2013 | 101.0% | $132.82 Million | $131.48 Million | $169.75 Million | $36.93 Million | ▼ -115.5 pp |
| 2012 | 216.5% | $95.03 Million | $43.90 Million | $130.14 Million | $35.11 Million | ▼ -9.1 pp |
| 2011 | 225.6% | $142.43 Million | $63.14 Million | $190.59 Million | $48.16 Million | — |